Canadian Association of Pediatric Ophthalmology

COS 6 - Clinical Update, Pediatrics

Saturday June 11, 2011, 1045-1215
Stanley Park 1&2

Objectives
At the end of this session, participants will be able to:

  • Describe the current trends in the use of anti-VEGF therapy for ROP in Canada.
  • Compare and contrast old and new concepts on the treatment of ROP, congenital nasolacrimal duct obstruction and dacryocele.

Moderator
Luis H. Ospina

1045Introduction
Luis H. Ospina
1050Evaluation and treatment of congenital nasolacrimal duct obstruction and dacryocele
François Codère
1115Discussion
1125ROP treatment: Pan-canadian survey
Robert Gizicki, Patrick Hamel, Rosanne Superstein, Nicole Fallaha, Luis H Ospina, Caroline Belanger, Mazn Choulakian, Sacha Chayestemehr
1150Discussion
1210Lunch